For the year ending 2025-12-31, VRTX has $25,643,000K in assets. $6,977,200K in debts. $5,084,800K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Cash and cash equivalents | 5,084,800 | 4,569,600 | 10,369,100 | 10,504,000 |
| Marketable securities | 1,523,300 | 1,546,300 | 849,200 | 274,500 |
| Accounts receivable, net | 2,052,800 | 1,609,400 | 1,563,400 | 1,442,200 |
| Inventories | 1,686,800 | 1,205,400 | 738,800 | 460,600 |
| Prepaid expenses and other current assets | 853,300 | 665,700 | 623,700 | 553,500 |
| Total current assets | 11,201,000 | 9,596,400 | 14,144,200 | 13,234,800 |
| Property and equipment, net | 1,520,300 | 1,227,800 | 1,159,300 | 1,108,400 |
| Goodwill | 1,088,000 | 1,088,000 | 1,088,000 | 1,088,000 |
| Other intangible assets, net | 424,200 | 825,900 | 839,900 | 603,600 |
| Deferred tax assets | 2,897,900 | 2,331,100 | 1,812,100 | 1,246,900 |
| Operating lease assets | 1,562,700 | 1,356,800 | 293,600 | 347,400 |
| Long-term marketable securities | 5,712,300 | 5,107,900 | 2,497,800 | - |
| Other assets | 1,236,600 | 999,300 | 895,300 | 521,800 |
| Total assets | 25,643,000 | 22,533,200 | 22,730,200 | 18,150,900 |
| Accounts payable | 461,700 | 413,000 | 364,900 | 303,900 |
| Accrued expenses | 2,971,200 | 2,788,600 | 2,655,300 | 2,126,700 |
| Other current liabilities | 428,300 | 363,000 | 527,200 | 311,500 |
| Total current liabilities | 3,861,200 | 3,564,600 | 3,547,400 | 2,742,100 |
| Long-term finance lease liabilities | - | 112,800 | 376,100 | 430,800 |
| Long-term operating lease liabilities | 1,846,500 | 1,544,400 | 348,600 | 379,500 |
| Other long-term liabilities | 1,269,500 | 901,800 | 877,700 | 685,800 |
| Total liabilities | 6,977,200 | 6,123,600 | 5,149,800 | 4,238,200 |
| Common stock, 0.01 par value 500,000,000 shares authorized, 253,991,224 and 256,940,382 shares issued and outstanding, respectively | 2,500 | 2,600 | 2,600 | 2,600 |
| Additional paid-in capital | 5,119,200 | 6,672,400 | 7,449,700 | 7,386,500 |
| Accumulated other comprehensive (loss) income | -15,900 | 127,800 | -14,300 | 800 |
| Retained earnings | 13,560,000 | 9,606,800 | 10,142,400 | 6,522,800 |
| Total shareholders equity | 18,665,800 | 16,409,600 | 17,580,400 | 13,912,700 |
| Total liabilities and shareholders equity | 25,643,000 | 22,533,200 | 22,730,200 | 18,150,900 |
VERTEX PHARMACEUTICALS INC MA (VRTX)
VERTEX PHARMACEUTICALS INC MA (VRTX)